Results 71 to 80 of about 141,900 (251)

Clomiphene citrate induced kidney injury in female albino rat [PDF]

Journal of Bioscience and Applied Research, 2015
Clomiphene citrate (clomid), a selective oestrogen-receptor modulator, is used in the treatment of polycystic ovary syndrome. On the other hand, it showed many adverse effects.
Hawazen Lamfon, Nahid Lamfon
doaj   +1 more source

The Effect of Hypnotherapy on the Resilience of Women With Polycystic Ovarian Syndrome: Study Protocol for a Randomized Controlled Trial

Health Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background and Aims Polycystic ovarian syndrome, with a mean incidence of 5–10, is the most common endocrine disorder affecting women of reproductive age. These patients suffer from a wide range of symptoms that are inversely related to their resilience and quality of life.
Soghra Khani, Zohreh Shahhosseini, Mahdi pourasghar, Roya Nikbakht, Mahtab Hajimohammadreza   +4 more
wiley   +1 more source

Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: A randomized controlled trial

Reproductive Biology and Endocrinology, 2011
Background The aim of this randomized controlled trial was to compare the efficacy of extended letrozole regimen with clomiphene citrate in women with unexplained infertility undergoing superovulation and intrauterine insemination (IUI).
Sayed Ahmed M, Fouda Usama M
doaj   +1 more source

Pulmonary Embolism as a Rare Complication of Clomiphene Therapy: A Case Report and Literature Review

Case Reports in Endocrinology, 2021
Background. Pulmonary embolism (PE) is a medical emergency. Certain medications like oral contraceptives and hormone replacement therapies have been associated with PE.
Vinod Solipuram, Kishor Pokharel, Temple Ihedinmah   +2 more
doaj   +1 more source

The position of diagnostic laparoscopy in current fertility practice [PDF]

, 2007
In everyday clinical practice, it is not always clear if and when exactly in the fertility work-up a diagnostic laparoscopy should be offered. The aim of this review is to analyse the available evidence with respect to alternative diagnostic methods for ...
Bosteels, Jan, D'Hooghe, Thomas, Van Herendael, Bruno, Weyers, Steven   +3 more
core   +1 more source

Gynecologic surgery for benign disease: Preserving reproductive potential

International Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1022-1028, December 2025.
Abstract Preserving fertility is essential when managing benign gynecologic disorders in reproductive‐aged women. Surgical interventions can impact future fertility, therefore requiring an evidence‐based, individualized approach. The FIGO Committee on Reproductive Endocrinology and Infertility reviewed current literature to develop recommendations for ...
Togas Tulandi, Edgar Mocanu, Nikhil Purandare, Scott M. Nelson, Eytan R. Barnea, Ruth Dolmo Carluccio, Elif Goknur Topcu, Dov Feldberg, FIGO Committee on Reproductive Endocrinology and Infertility, Nikhil Purandare, M. Louise Hull, Ajey Bhardwaj, Andres Calle, Dov Feldberg, Edgar Mocanu, Eytan Barnea, Goknur Topcu, Hrishikesh Pai, Henry Laurie, Ivonne Jeannette Diaz Yamal, Jaideep Malhotra, Gitau Mburu, Scott Nelson, Togas Tulandi   +23 more
wiley   +1 more source

A Review of Second- and Third-line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome

Medical Sciences, 2019
In clomiphene-citrate-resistant anovulatory women with polycystic ovary syndrome (PCOS) and no other infertility factors, either metformin combined with clomiphene citrate or gonadotrophins could be used as a second-line pharmacological therapy, although
Michael F. Costello, Rhonda M. Garad, Roger Hart, Hayden Homer, Louise Johnson, Cailin Jordan, Edgar Mocanu, Jie Qiao, Luk Rombauts, Helena J. Teede, Eszter Vanky, Christos A. Venetis, William L. Ledger   +12 more
doaj   +1 more source

Testosterone Replacement, Where Are We in 2025?

Trends in Urology &Men's Health, Volume 16, Issue 6, December 2025.
ABSTRACT Testosterone replacement therapy has evolved significantly in recent years, driven by high‐quality clinical evidence and expanded treatment options. The 2023 TRAVERSE trial provided definitive cardiovascular safety data, leading to FDA removal of black box warnings in 2025 and altering the clinical approach to testosterone therapy.
Arnaav Walia, Peyton Coady, Beatriz Sofia‐Hernandez, Haarika Gudlavalleti, Adnan El‐Achkar, Shannon Elise Dunnam, Vinayak Madhusoodanan, Taylor Kohn, Mohit Khera   +8 more
wiley   +1 more source

Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome [PDF]

, 1998
Background Obese women with the polycystic ovary syndrome are relatively unresponsive to the induction of ovulation by clomiphene. We hypothesized that reducing insulin secretion by administering metformin would increase the ovulatory response to ...
Evans, William S., , M.D., Jakubowicz, Daniela J., , M.D., Nestler, John E., , M.D., Pasquali, Renato, , M.D.   +3 more
core   +2 more sources

Addressing Demographic Challenges Through Public–Private Partnerships: In Vitro Fertilization in Latvia

World Medical &Health Policy, Volume 17, Issue 4, Page 688-694, December 2025.
ABSTRACT The study by Morshed‐Behbahani et al. highlights that financial barriers are not the sole obstacle to accessing infertility treatment. To ensure equal access for all, infertility treatment should be regarded as a universal human right, with the public sector assuming responsibility for its provision.
Arturs Kalva, Girts Brigis
wiley   +1 more source